Bioorganic and Medicinal Chemistry Letters p. 3171 - 3176 (1998)
Update date:2022-08-03
Topics: Antagonist Nonpeptide Imidazopyridine-containing 1,4-benzodiazepine Vitronectin receptor (αvβ3) Restenosis
Keenan, Richard M.
Lago, M. Amparo
Miller, William H.
Ali, Fadia E.
Cousins, Russell D.
Hall, Leon B.
Hwang, Shing-Mei
Jakas, Dalia R.
Kwon, Chet
Louden, Calvert
Nguyen, Thomas T.
Ohlstein, Eliot H.
Rieman, David J.
Ross, Steven T.
Samanen, James M.
Smith, Brian R.
Stadel, Jeffrey
Takata, Dennis T.
Vickery, Lynne
Yuan, Catherine C. K.
Yue, Tian-Li
In the 3-oxo-1,4-benzodiazepine-2-acetic acid series of vitronectin receptor (αvβ3) antagonists, a compound containing an imidazopyridine arginine mimetic was discovered which had sufficient potency and iv pharmacokinetics for demonstration of efficacy in a rat restenosis model.
View MoreFeiyang Biotechnology Co., Ltd.
Contact:+86-533-7866339
Address:Qilu Chemistry Park, 200m north of Management Community Building of Park
Contact:+86-25-83719363
Address:106-7 Chunnan Rd, Chunxi Town, Gaochun, Nanjing, China
Contact:+86-0512-62857507
Address:Boji Science Park, No1688C,Taishan road, Suzhou ,China
Nanjing Norris Pharm Technology Co., Ltd.
Contact:+86-13901585132
Address:2 Qiande Road, Jiangning sciencepark Hi-Tech Zone, Nanjing, P.R.China
Contact:+86-579-85206992
Address:No 451 chouzhou north road ,room 1106 int'l business center , yiwu ,china
Doi:10.1021/ja01874a037
(1939)Doi:10.1016/S0960-894X(97)10201-3
(1998)Doi:10.1021/ol034287r
(2003)Doi:10.3987/COM-97-8038
(1998)Doi:10.1002/zaac.19976230807
(1997)Doi:10.1039/c7ra03238b
(2017)